Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
On October 23rd, Puerta de Hierro Majadahonda University Hospital joined the RESILIENCE project, so hopefully it will begin to incorporate patients into the trial in the coming days. This hospital was created in 1964 and, since then, it has fulfilled a triple function: care, teaching and research. Currently, as a public institution dependent on the […]
